Literature DB >> 18337717

Managing anemia in dialysis patients: hemoglobin cycling and overshoot.

Ajay K Singh1, Edgar Milford, Steven Fishbane, Sai Ram Keithi-Reddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18337717     DOI： 10.1038/ki.2008.59

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  9 in total

1.  The Role of Feedback Control Design in Developing Anemia Management Protocols.

Authors:  Yossi Chait; Michael J Germain; Christopher V Hollot; Joseph Horowitz
Journal:  Ann Biomed Eng       Date:  2020-05-07       Impact factor: 3.934

2.  The effect of empowerment on the self-efficacy, quality of life and clinical and laboratory indicators of patients treated with hemodialysis: a randomized controlled trial.

Authors:  Marzieh Moattari; Marzieh Ebrahimi; Nasrin Sharifi; Jamshid Rouzbeh
Journal:  Health Qual Life Outcomes       Date:  2012-09-20       Impact factor: 3.186

3.  Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: is it feasible?

Authors:  Luca Gabutti; Filippo Nobile; Valentina Forni; Fabio Rigamonti; Nadir Weibel; Michel Burnier
Journal:  BMC Nephrol       Date:  2011-02-18       Impact factor: 2.388

4.  Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis.

Authors:  Irfan Khan; Mahesh Krishnan; Anupam Kothawala; Akhtar Ashfaq
Journal:  BMC Nephrol       Date:  2011-05-20       Impact factor: 2.388

5.  Individualizing anaemia therapy.

Authors:  Angel L M de Francisco
Journal:  NDT Plus       Date:  2010-09-21

6.  A Safe and Easy Introduction of Darbepoetin-Alpha in Patients Receiving Maintenance Hemodialysis and Epoetin Monotherapy: A "Half-and-Half" Combination Therapy.

Authors:  Kazumasa Shimamatsu; Hiroko Inamasu
Journal:  Curr Ther Res Clin Exp       Date:  2013-06

7.  Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial.

Authors:  Valentina Forni; Giorgia Bianchi; Adam Ogna; Igor Salvadé; Philippe Vuistiner; Michel Burnier; Luca Gabutti
Journal:  BMC Nephrol       Date:  2013-07-22       Impact factor: 2.388

8.  Does erythropoietin cause hemoglobin variability--is it 'normal'?

Authors:  Ashwani K Gupta; Waseem David
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

9.  Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.

Authors:  Carlo Barbieri; Elena Bolzoni; Flavio Mari; Isabella Cattinelli; Francesco Bellocchio; José D Martin; Claudia Amato; Andrea Stopper; Emanuele Gatti; Iain C Macdougall; Stefano Stuard; Bernard Canaud
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.